Abstract:Spinal cord glioma is a tumor characterized by high recurrence and mortality rates, and its treatment remains a major challenge. It has been reported that abnormal expression of microRNAs (miRNAs/miRs) is associated with tumor progression. Therefore, the current study aimed to identify novel miRNAs associated with spinal cord glioma. Herein, the expression levels of several miRNAs were determined in human spinal cord glioma and adjacent non-cancerous tissues by reverse transcription-quantitative (RT-qPCR). The results revealed that miR-106a-5p expression was markedly upregulated in spinal cord glioma tissues compared with in non-cancerous tissues. Furthermore, the biological effects of miR-106a-5p on spinal cord glioma cells were evaluated by MTT, Transwell and flow cytometric assays. In 0231SCG cells transfected with miR-106a-5p inhibitor, cell proliferation, migration and invasion were attenuated, whereas apoptosis was enhanced. A search of the TargetScan database revealed that miR-106a-5p directly targeted CUGBP Elav-like family member 2 (CELF-2). Western blot and RT-qPCR experiments further confirmed the association between miR-106a-5p and CELF-2 expression in spinal cord glioma tissues. The current results demonstrated that CELF-2 was a direct target of miR-106a-5p, and that the expression levels of CELF-2 were negatively associated with those of miR-106a-5p. In addition, overexpression of CELF-2 in spinal cord glioma cells reversed the tumor-promoting effects of miR-106a-5p both in vitro and in vivo. Overall, the aforementioned findings indicated that miR-106a-5p, which was highly expressed in spinal cord glioma tissues, may affect the proliferation, migration, invasion and apoptosis of spinal cord glioma cells via targeting CELF-2, thus indicating a potential approach to the future clinical management of spinal cord glioma.

MiR-106a Inhibits Glioma Cell Growth by Targeting E2F1 Independent of P53 Status.

Down-regulation of miR-106b suppresses the growth of human glioma cells

MicroRNA-106b-5p Boosts Glioma Tumorigensis by Targeting Multiple Tumor Suppressor Genes

MicroRNA-320 Inhibits Cell Proliferation in Glioma by Targeting E2F1

MicroRNA-181 Inhibits Glioma Cell Proliferation by Targeting Cyclin B1.

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

Suppression of Mir-106A-5p Expression Inhibits Tumorigenesis Via Increasing CELF-2 Expression in Spinal Cord Glioma.

MiR-106a is an Independent Prognostic Marker in Patients with Glioblastoma.

MicroRNA-1468-5p Inhibits Glioma Cell Proliferation and Induces Cell Cycle Arrest by Targeting RRM1.

The repressive effect of antisense miR-106b on human glioma cell growth and invasive ability

Mir-216B Inhibits Glioma Cell Migration and Invasion Through Suppression of FoxM1

Decreased Mir-106A Inhibits Glioma Cell Glucose Uptake and Proliferation by Targeting SLC2A3 in GBM

MicroRNA-1179 Inhibits Glioblastoma Cell Proliferation and Cell Cycle Progression Via Directly Targeting E2F Transcription Factor 5.

The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MicroRNA-128 Inhibits Glioma Cells Proliferation by Targeting Transcription Factor E2F3a

The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines

MicroRNA-16 Inhibits Glioma Cell Growth and Invasion Through Suppression of BCL2 and the Nuclear Factor-Κb1/mmp9 Signaling Pathway.

MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.

MiRNA-451 plays a role as tumor suppressor in human glioma cells.